$11.00
+0.92 (+9.13%)
Analyst Consensus
Strong Buy
12
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+305.0% upside
Low Target
$33.16
Average Target
$44.55
High Target
$53.28
Current Price
$11.00
Current
$11.00
$11.00
Target
$44.55
$44.55
$33.16
$44.55 avg
$53.28
Scenario Analysis
Bear Case
$33.16
201.5%
Low target
Base Case
$44.55
+305.0%
Avg target
Bull Case
$53.28
+384.4%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$17.15
-35.9% from high
52-Week Low
$10.06
+9.3% from low
Target vs 52W High
$44.55
+159.8% vs high
Next Earnings Report
Nov 16, 2026 · After Market Close
5d
until earnings
EPS Est: $-0.80
Earnings in 5 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 38 | 82% | $257.58 | -12.4% |
| AMGN | Hold | 42 | 43% | $190.87 | -58.8% |
| GILD | Strong Buy | 36 | 83% | $362.68 | +113.5% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -20.3% |
| MRNA | Hold | 31 | 32% | $149.45 | -42.1% |
| REGN | Buy | 36 | 72% | $76.80 | -91.6% |
| NTRA | Strong Buy | 31 | 90% | $142.91 | -54.5% |
| RVMD | Strong Buy | 31 | 94% | $114.11 | -40.3% |